-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
VYNE Therapeutics Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2019 to Q3 2024.
- VYNE Therapeutics Inc. Costs and Expenses for the quarter ending September 30, 2024 was $13.2M, a 108% increase year-over-year.
- VYNE Therapeutics Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $38.2M, a 24.1% increase year-over-year.
- VYNE Therapeutics Inc. annual Costs and Expenses for 2023 was $29.7M, a 14.6% decline from 2022.
- VYNE Therapeutics Inc. annual Costs and Expenses for 2022 was $34.8M, a 12.7% decline from 2021.
- VYNE Therapeutics Inc. annual Costs and Expenses for 2021 was $39.8M, a 85.4% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)